Literature DB >> 26424643

Epstein-Barr Virus Strain Variation.

Paul J Farrell1.   

Abstract

What is wild-type Epstein-Barr virus and are there genetic differences in EBV strains that contribute to some of the EBV-associated diseases? Recent progress in DNA sequencing has resulted in many new Epstein-Barr virus (EBV) genome sequences becoming available. EBV isolates worldwide can be grouped into type 1 and type 2, a classification based on the EBNA2 gene sequence. Type 1 transforms human B cells into lymphoblastoid cell lines much more efficiently than type 2 EBV and molecular mechanisms that may account for this difference in cell transformation are now becoming understood. Study of geographic variation of EBV strains independent of the type 1/type 2 classification and systematic investigation of the relationship between viral strains, infection and disease are now becoming possible. So we should consider more directly whether viral sequence variation might play a role in the incidence of some EBV-associated diseases.

Entities:  

Keywords:  DNA sequence; Epstein–barr virus; Genome; Strain; Variation

Mesh:

Substances:

Year:  2015        PMID: 26424643     DOI: 10.1007/978-3-319-22822-8_4

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  17 in total

Review 1.  Epigenetics and Genetics of Viral Latency.

Authors:  Paul M Lieberman
Journal:  Cell Host Microbe       Date:  2016-05-11       Impact factor: 21.023

2.  Epidemiology of the Epstein-Barr Virus in Autoimmune Inflammatory Rheumatic Diseases in Northern Brazil.

Authors:  Samires Avelino de Souza França; Julimar Benedita Gomes de Oliveira Viana; Hilda Carla Azevedo Góes; Ricardo Roberto de Souza Fonseca; Rogério Valois Laurentino; Igor Brasil Costa; Aldemir Branco Oliveira-Filho; Luiz Fernando Almeida Machado
Journal:  Viruses       Date:  2022-03-27       Impact factor: 5.818

Review 3.  Epstein-Barr virus infection and nasopharyngeal carcinoma.

Authors:  Sai Wah Tsao; Chi Man Tsang; Kwok Wai Lo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

4.  Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains.

Authors:  Teru Kanda; Yuki Furuse; Hitoshi Oshitani; Tohru Kiyono
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

5.  Association between Epstein-Barr Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females.

Authors:  Meravt Mashaly; Doaa Ghorab; Mohamed Hegazy; Mohamed Abdelkhalek; Khaled Gaballah; Rasha Elzehery
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

6.  Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar.

Authors:  Maria K Smatti; Hadi M Yassine; Raed AbuOdeh; Asmaa AlMarawani; Sara A Taleb; Asmaa A Althani; Gheyath K Nasrallah
Journal:  PLoS One       Date:  2017-12-11       Impact factor: 3.240

7.  Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency.

Authors:  Jayaraju Dheekollu; Kimberly Malecka; Andreas Wiedmer; Henri-Jacques Delecluse; Alan K S Chiang; Dario C Altieri; Troy E Messick; Paul M Lieberman
Journal:  Oncotarget       Date:  2017-01-31

Review 8.  The Role of aDNA in Understanding the Coevolutionary Patterns of Human Sexually Transmitted Infections.

Authors:  Ville N Pimenoff; Charlotte J Houldcroft; Riaan F Rifkin; Simon Underdown
Journal:  Genes (Basel)       Date:  2018-06-25       Impact factor: 4.096

9.  Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.

Authors:  Samantha Correia; Anne Palser; Claudio Elgueta Karstegl; Jaap M Middeldorp; Octavia Ramayanti; Jeffrey I Cohen; Allan Hildesheim; Maria Dolores Fellner; Joelle Wiels; Robert E White; Paul Kellam; Paul J Farrell
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

10.  Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture.

Authors:  Jerome E Tanner; Jing Hu; Caroline Alfieri
Journal:  Cancers (Basel)       Date:  2018-04-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.